Centerpoint Advisory Group Maia Biotechnology, Inc. Transaction History
Centerpoint Advisory Group
- $128 Billion
- Q3 2025
A detailed history of Centerpoint Advisory Group transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Centerpoint Advisory Group holds 15,730 shares of MAIA stock, worth $16,359. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,730
Previous 15,730
-0.0%
Holding current value
$16,359
Previous $28.3 Million
14.45%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding MAIA
# of Institutions
20Shares Held
2.35MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.1MShares$1.15 Million0.0% of portfolio
-
Centric Wealth Management575KShares$597,8930.21% of portfolio
-
Geode Capital Management, LLC Boston, MA271KShares$281,8980.0% of portfolio
-
Marshall Wace, LLP London, X0110KShares$114,8850.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$81,6610.0% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $11.4M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...